Yoga for Pain and Opioid Dependence (Yoga)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01590251 |
Recruitment Status :
Completed
First Posted : May 2, 2012
Last Update Posted : September 25, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Pain Opioid Addiction | Other: Yoga Behavioral: Educational Counseling | Phase 1 Phase 2 |
This study aims to develop an adjunctive novel treatment intervention using yoga in opioid agonist maintained patients to effectively treat the co-occurring disorders of non-malignant chronic pain and opioid dependence (POD).
Specific Aims:
1) To conduct a pre-pilot phase with 8 patients with POD receiving opioid agonist maintenance treatment.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 8 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Yoga for Pain and Opioid Dependence |
Study Start Date : | April 2012 |
Actual Primary Completion Date : | November 2014 |
Actual Study Completion Date : | November 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: Yoga
Gentle yoga for chronic pain and opioid dependence
|
Other: Yoga
Two yoga sessions per week for 8 weeks (one yoga session is instructional, the other is a practice session. |
Active Comparator: Educational Counseling
Educational counseling is a didactic, lecture-discussion format to supplement the information and advice provided in opioid agonist maintenance treatment.
|
Behavioral: Educational Counseling
One didactic session per week of approximately 50 minutes that provides information about chronic pain and substance abuse disorders. |
- Pain reduction [ Time Frame: 8 weeks ]Pain reduction will be measured by patient self-report using standard pain rating scales.
- Reduce illicit opioid use [ Time Frame: 8 weeks ]Reduced illicit opioid use will be measured by patient self-report and urinalysis testing.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years of age or older
- Prescription opioid addiction or heroin addiction
- Moderate to severe chronic pain,
- Understands English
Exclusion Criteria:
- Current suicide or homicide risk
- Life threatening or unstable medical condition
- Medical or psychiatric condition that is judged to be of clinical concern by the PI or admitting clinician
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01590251
United States, Connecticut | |
MRU | |
New Haven, Connecticut, United States, 06519 |
Principal Investigator: | Declan T Barry, Ph.D. | Yale University |
Responsible Party: | Yale University |
ClinicalTrials.gov Identifier: | NCT01590251 History of Changes |
Other Study ID Numbers: |
1111009292 |
First Posted: | May 2, 2012 Key Record Dates |
Last Update Posted: | September 25, 2015 |
Last Verified: | September 2015 |
Pain Addiction Buprenorphine |
Counseling Methadone Yoga |
Chronic Pain Opioid-Related Disorders Behavior, Addictive Pain Neurologic Manifestations Signs and Symptoms Compulsive Behavior Impulsive Behavior Substance-Related Disorders |
Chemically-Induced Disorders Mental Disorders Analgesics, Opioid Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |